These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25385558)

  • 61. Topical tacrolimus (FK506) in the treatment of recalcitrant parastomal pyoderma gangrenosum associated with Crohn's disease: report of two cases.
    Khurrum Baig M; Marquez H; Nogueras JJ; Weiss EG; Wexner SD
    Colorectal Dis; 2004 Jul; 6(4):250-3. PubMed ID: 15206967
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pyoderma gangrenosum-like ulceration as a presenting feature of pediatric granulomatosis with polyangiitis.
    Oz RS; Onajin O; Harel L; Tal R; Dallos T; Rosenblatt A; Plank L; Wagner-Weiner L
    Pediatr Rheumatol Online J; 2021 Jun; 19(1):81. PubMed ID: 34090470
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Pyoderma gangrenosum following hematopoietic stem cell transplantation].
    Eddou H; Ennouhi A; Sina M; Zinebi A; El Benaye J; Moudden MK; Doghmi K; Malfuson JV; Mikdame M; El Baaj M
    Ann Dermatol Venereol; 2018; 145(6-7):445-450. PubMed ID: 29747867
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Pregnancy: a possible etiology of pyoderma gangrenosum. A case report and review of the literature].
    Sergent F; Joly P; Gravier A; Verspyck E; Marpeau L
    J Gynecol Obstet Biol Reprod (Paris); 2002 Sep; 31(5):506-11. PubMed ID: 12379836
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Anti-tumor necrosis factor alpha monoclonal antibody (infliximab) for the treatment of Pyoderma gangrenosum associated with Crohn's disease.
    Zaccagna A; Bertone A; Puiatti P; Picciotto F; Sprujevnik T; Santucci R; Rossini FP
    Eur J Dermatol; 2003; 13(3):258-60. PubMed ID: 12804985
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical features and management of parastomal pyoderma gangrenosum in inflammatory bowel disease.
    Uchino M; Ikeuchi H; Matsuoka H; Bando T; Takahashi Y; Takesue Y; Matsumoto T; Tomita N
    Digestion; 2012; 85(4):295-301. PubMed ID: 22584791
    [TBL] [Abstract][Full Text] [Related]  

  • 67. What do autoinflammatory syndromes teach about common cutaneous diseases such as pyoderma gangrenosum? A commentary.
    Butler D; Shinkai K
    Dermatol Clin; 2013 Jul; 31(3):427-35. PubMed ID: 23827245
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Narrative Review: Pyoderma Gangrenosum.
    Park AN; Raj A; Bajda J; Gorantla VR
    Cureus; 2024 Jan; 16(1):e51805. PubMed ID: 38187026
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Management of peristomal pyoderma gangrenosum.
    Poritz LS; Lebo MA; Bobb AD; Ardell CM; Koltun WA
    J Am Coll Surg; 2008 Feb; 206(2):311-5. PubMed ID: 18222385
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Infliximab for treatment of resistant pyoderma gangrenosum associated with Crohn's disease.
    Ferkolj I; Hocevar A; Golouh R; Dolenc Voljc M
    Acta Dermatovenerol Alp Pannonica Adriat; 2006 Dec; 15(4):173-7. PubMed ID: 17982610
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pyoderma gangrenosum--a review.
    Wollina U
    Orphanet J Rare Dis; 2007 Apr; 2():19. PubMed ID: 17433111
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pyoderma gangrenosum following cesarean delivery.
    Steadman UA; Brennan TE; Daman LA; Curry SL
    Obstet Gynecol; 1998 May; 91(5 Pt 2):834-6. PubMed ID: 9572181
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Extraintestinal manifestations of Crohn's disease.
    Juillerat P; Mottet C; Froehlich F; Felley C; Vader JP; Burnand B; Gonvers JJ; Michetti P
    Digestion; 2005; 71(1):31-6. PubMed ID: 15711047
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Peristomal pyoderma gangrenosum after colectomy for Crohn disease. Successful medical treatment].
    Goudet P; Pillon D; Bensa F; Collet E; Cougard P; Viard H
    Ann Chir; 1992; 46(6):525-9. PubMed ID: 1444154
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pyoderma gangrenosum and impact on quality of life: A narrative review.
    Sanchez-Melendez SN; Malik R; Patel PM; Milosavljevic S; Patel S; Nambudiri VE
    Exp Dermatol; 2024 Jan; 33(1):e14876. PubMed ID: 37424357
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pyoderma gangrenosum as first manifestation of Crohn's disease.
    Rizzuto A; Gallo G; Trompetto M; Sacco R
    Tech Coloproctol; 2019 Jan; 23(1):79-80. PubMed ID: 30656577
    [No Abstract]   [Full Text] [Related]  

  • 77. Extraintestinal manifestations of Crohn's disease.
    Juillerat P; Mottet C; Pittet V; Froehlich F; Felley C; Gonvers JJ; Vader JP; Michetti P
    Digestion; 2007; 76(2):141-8. PubMed ID: 18239406
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A novel murine model of pyoderma gangrenosum reveals that inflammatory skin-gut crosstalk is mediated by IL-1β-primed neutrophils.
    Jatana S; Ponti AK; Johnson EE; Rebert NA; Smith JL; Fulmer CG; Maytin EV; Achkar JP; Fernandez AP; McDonald C
    Front Immunol; 2023; 14():1148893. PubMed ID: 37475852
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Pyoderma gangrenosum, subcorneal IgA pustulosis and recurrent neutrophilic pleural and pulmonary diseases in a patient with IgA gammopathy].
    Cartier H; Plantin P; Leroy JP; Larzul JJ
    Ann Dermatol Venereol; 1995; 122(3):97-101. PubMed ID: 7486731
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A Rare Coexistence: Cutaneous Lobular Carcinoma with Pyoderma Gangrenosum.
    Sutton S; Haran K; Mullins A; Lamerson C
    Am J Case Rep; 2024 Mar; 25():e942488. PubMed ID: 38531543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.